Antitrust Issues in Generic Substitution: How Pharma Tactics Block Cheaper Drugs
Pharmaceutical companies are using product hopping and REMS abuse to block generic substitution, costing patients billions. Learn how FTC enforcement is fighting back against these anti-competitive tactics.